Skip to main content
. 2014 Sep 5;9(9):e106623. doi: 10.1371/journal.pone.0106623

Table 1. Baseline characteristics of 2,197 Chinese with type 2 diabetes with and without asymptomatic MCA stenosis.

Characteristic Overall (n = 2197) MCA stenosis (n = 272) No MCA stenosis (n = 1925) p-value*
Age, years 55.4 (11.3) 59.3 (10.8) 54.8 (11.3) <0.001
Male, n(%) 896 (40.8) 102 (37.5) 794 (41.2) 0.24
BMI, kg/m2 24.9 (3.7) 24.4 (3.6) 24.9 (3.7) 0.03
Waist circumference, cm 84.6 (9.6) 83.6 (9.7) 84.7 (9.6) 0.11
Systolic blood pressure, mmHg 138.4 (21.5) 147.4 (23.1) 137.2 (21.0) <0.001
Dystolic blood pressure, mmHg 78.9 (11.4) 78.7 (11.9) 78.9 (11.3) 0.82
Total cholesterol, mmol/l 5.6 (1.1) 5.8 (1.3) 5.6 (1.1) 0.02
Triglycerides, mmol/l 1.8 (1.6) 1.7 (1.4) 1.8 (1.7) 0.42
LDL cholesterol, mmol/l 3.6 (0.9) 3.8 (1.1) 3.6 (0.9) 0.003
HDL cholesterol, mmol/l 1.26 (0.36) 1.27 (0.35) 1.26 (0.36) 0.77
Fasting glucose, mmol/l 9.06 (3.5) 9.06 (3.3) 9.06 (3.5) 0.99
HbA1c, % 7.9 (1.9) 7.9 (1.8) 7.8 (1.9) 0.51
HbA1c, mmol/mol 62.3 (20.3) 63.2 (19.8) 62.1 (20.4) 0.44
Medical history, n(%)
Smoking 599 (27.3) 80 (29.4) 519 (27.0) 0.40
Diabetes duration, mo. 81.1 (72.9) 99.8 (79.5) 78.5 (71.5) <0.001
Hypertension 1155 (52.6) 195 (71.7) 960 (49.9) <0.001
IHD history 62 (2.8) 16 (5.9) 46 (2.4) 0.001
Albuminuria 659 (30.0) 104 (39.4) 555 (29.7) 0.001
Peripheral arterial disease 46 (2.1) 14 (5.3) 32 (1.7) <0.001
Retinopathy 506 (23.0) 96 (35.3) 410 (21.3) <0.001
Medication, n(%)
Hypoglycemic therapy 1901 (86.5) 250 (91.9) 1651 (85.9) 0.007
Aspirin 32 (1.5) 11 (4.0) 21 (1.1) <0.001
Antihypertensive therapy 423 (19.3) 75 (27.6) 348 (18.1) <0.001
Statin 112 (5.1) 22 (8.1) 90 (4.7) 0.02

Data are mean ± SD or n (%).

BMI, body mass index; ACEI, angiotensin-converting enzyme inhibitors; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MCA, middle cerebral artery; IHD: ischemic heart disease.

Hypertension was defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg, or the use of ACE inhibitors, angiotensin II receptor blockers, or other antihypertensive drugs.

*P values refer to comparisons between groups with and without MCA stenosis.

From independent-samples t test.

From χ2-squared test.